Related references
Note: Only part of the references are listed.Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers: Disease Phase Influences Correlation with Viral Load and Intrahepatic Hepatitis B Virus Markers
Alexander J. V. Thompson et al.
HEPATOLOGY (2010)
Change in Serum Hepatitis B Surface Antigen Level and Its Clinical Significance in Treatment-naive, Hepatitis B e Antigen-positive Patients Receiving Entecavir
Young Kul Jung et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
Wei Cai et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative Patients
Rami Moucari et al.
HEPATOLOGY (2009)
Hepatitis B Virus Surface Antigen Levels: A Guide to Sustained Response to peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B
Maurizia Rossana Brunetto et al.
HEPATOLOGY (2009)
Monitoring During and After Antiviral Therapy for Hepatitis B
Karin L. Andersson et al.
HEPATOLOGY (2009)
Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B
Pisit Tangkijvanich et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Early hepatitis B virus DNA suppression can predict virologic response to peginterferon and lamivudine treatment
Henry Lik-Yuen Chan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Correlation of Quantitative Assay of HBsAg and HBV DNA Levels During Chronic HBV Treatment
Resat Ozaras et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2008)
Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response
Man-Fung Yuen et al.
HEPATOLOGY (2007)
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response
Henry Lik-Yuen Chan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
Karsten Wursthorn et al.
HEPATOLOGY (2006)
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy
JJY Sung et al.
GASTROENTEROLOGY (2005)
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle-Lapostolle et al.
GASTROENTEROLOGY (2004)
Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature
H Mommeja-Marin et al.
HEPATOLOGY (2003)
Hepatitis B virus-specific T-cell reactivity during adefovir dipivoxil (ADV) treatment: A multicentre, controlled study
H Cooksley et al.
JOURNAL OF HEPATOLOGY (2002)
Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection
YF Fan et al.
HEPATOLOGY (2001)
Share Paper
